Masahiro Mori
#179,117
Most Influential Person Now
Researcher
Masahiro Mori's AcademicInfluence.com Rankings
Masahiro Moricomputer-science Degrees
Computer Science
#11222
World Rank
#11864
Historical Rank
Machine Learning
#5133
World Rank
#5198
Historical Rank
Artificial Intelligence
#5540
World Rank
#5618
Historical Rank
Database
#8256
World Rank
#8618
Historical Rank
Download Badge
Computer Science
Masahiro Mori's Degrees
- Bachelors Computer Science Imperial University of Japan
- Masters Artificial Intelligence Kyoto University
- PhD Robotics Osaka University
Similar Degrees You Can Earn
Why Is Masahiro Mori Influential?
(Suggest an Edit or Addition)Masahiro Mori's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study (2018) (559)
- Clinical features and prognosis of Miller Fisher syndrome (2001) (398)
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study (2017) (341)
- Axonal Guillain‐Barré syndrome: Relation to anti‐ganglioside antibodies and Campylobacter jejuni infection in Japan (2000) (335)
- Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7. (2004) (317)
- Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6 (2010) (261)
- Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial (2018) (176)
- Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis (2018) (163)
- ADRP/adipophilin is degraded through the proteasome-dependent pathway during regression of lipid-storing cells Published, JLR Papers in Press, October 17, 2005. (2006) (137)
- Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7 Published, JLR Papers in Press, March 22, 2007. (2007) (136)
- Long term prognosis of chronic inflammatory demyelinating polyneuropathy: a five year follow up of 38 cases (2005) (133)
- Intravenous immunoglobulin therapy for Miller Fisher syndrome (2007) (127)
- Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial (2020) (127)
- “Cloud‐like enhancement” is a magnetic resonance imaging abnormality specific to neuromyelitis optica (2009) (119)
- Haemophilus influenzae infection and Guillain-Barré syndrome. (2000) (118)
- Recovery patterns and long term prognosis for axonal Guillain–Barré syndrome (2005) (113)
- Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis (2009) (113)
- Hyperreflexia in Guillain-Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody (1999) (112)
- Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome (2005) (110)
- Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody (1998) (109)
- Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay (2008) (106)
- Differences in membrane properties of axonal and demyelinating Guillain‐Barré syndromes (2002) (105)
- Different responses to interferon beta‐1b treatment in patients with neuromyelitis optica and multiple sclerosis (2010) (104)
- RGMa modulates T cell responses and is involved in autoimmune encephalomyelitis (2011) (101)
- Differences in patterns of progression in demyelinating and axonal Guillain–Barré syndromes (2003) (100)
- “Bright spotty lesions” on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis (2014) (98)
- Does Campylobacter jejuni infection elicit “demyelinating” Guillain–Barré syndrome? (2004) (96)
- Long-chain fatty acids induce lipid droplet formation in a cultured human hepatocyte in a manner dependent of Acyl-CoA synthetase. (2006) (96)
- Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: Specificity, sensitivity, and a possible prognostic value (2011) (92)
- Different electrophysiological profiles and treatment response in ‘typical’ and ‘atypical’ chronic inflammatory demyelinating polyneuropathy (2014) (91)
- Worldwide prevalence of neuromyelitis optica spectrum disorders (2018) (90)
- Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy (2002) (88)
- Acute motor axonal neuropathy after Mycoplasma infection (2004) (87)
- Indicators of rapid clinical recovery in Guillain-Barré syndrome (2001) (82)
- Serum levels of tumor necrosis factor–α in chronic inflammatory demyelinating polyneuropathy (2001) (81)
- Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies (2000) (80)
- Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis (1999) (78)
- Transient Increase in Plasma Oxidized LDL During the Progression of Atherosclerosis in Apolipoprotein E Knockout Mice (2009) (78)
- Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks. (2013) (77)
- Emotional sweating response in a patient with bilateral amygdala damage. (2003) (76)
- Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis (2014) (76)
- Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome (2012) (74)
- Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies (2009) (69)
- Rho‐kinase inhibition enhances axonal regeneration after peripheral nerve injury (2006) (68)
- Foam cell formation containing lipid droplets enriched with free cholesterol by hyperlipidemic serum. (2001) (68)
- Haemophilus influenzae has a GM1 ganglioside-like structure and elicits Guillain–Barré syndrome (1999) (66)
- Hyperreflexia in axonal Guillain–Barré syndrome subsequent to Campylobacter jejuni enteritis (2002) (57)
- Minimally modified LDL is an oxidized LDL enriched with oxidized phosphatidylcholines. (2003) (57)
- Fisher syndrome: clinical features, immunopathogenesis and management (2012) (56)
- Intravenous immunoglobulin therapy for Guillain–Barré syndrome with IgG anti‐GM1 antibody (2001) (56)
- The refractory period of transmission is impaired in axonal Guillain–Barré syndrome (2003) (56)
- Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: Correlation with clinical profiles (2004) (52)
- Neuromyelitis optica: Concept, immunology and treatment (2014) (51)
- Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome (2014) (51)
- Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood–brain barrier disruption (2017) (48)
- Plasmapheresis and Miller Fisher syndrome: analysis of 50 consecutive cases (2002) (48)
- Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein. (2000) (47)
- Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis (2006) (46)
- Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection (2003) (46)
- Peripheral nerve demyelination in multiple sclerosis (2008) (46)
- Anti‐high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis (2013) (45)
- CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica (2012) (44)
- Association of anti-aquaporin-4 antibody-positive neuromyelitis optica with myasthenia gravis (2009) (44)
- Axonal involvement at the common entrapment sites in Guillain‐Barré syndrome with IgG anti‐GM1 antibody (1999) (44)
- Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial (2018) (43)
- Transmembrane Lipid Transfer Is Crucial for Providing Neutral Lipids during Very Low Density Lipoprotein Assembly in Endoplasmic Reticulum* (2003) (43)
- Anti-GM1 antibody IgG subclass (2003) (42)
- CSF interleukin-6 level predicts recovery from neuromyelitis optica relapse (2011) (42)
- How often and when Fisher syndrome is overlapped by Guillain‐Barré syndrome or Bickerstaff brainstem encephalitis? (2016) (42)
- IgG anti-GQ1b positive acute ataxia without ophthalmoplegia (1999) (41)
- Chronic Intractable Headache in a Patient With Marfan's Syndrome (1997) (40)
- Sensory Nerve Conduction in Demyelinating and Axonal Guillain-Barré Syndromes (2004) (40)
- Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood-brain barrier breakdown in neuromyelitis optica. (2011) (40)
- Micturitional disturbance in Wernicke's encephalopathy (1998) (39)
- Micturitional disturbance in herpetic brainstem encephalitis; contribution of the pontine micturition centre (1998) (39)
- Prevalence and mechanism of bladder dysfunction in Guillain–Barré Syndrome (2009) (38)
- Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial (2017) (37)
- Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica (2013) (36)
- Successful immune treatment for non-paraneoplastic limbic encephalitis (2002) (36)
- Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy (2015) (34)
- Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction (2017) (32)
- Dopamine agonist‐induced antecollis in Parkinson's disease (2009) (32)
- Soluble CD40 ligand contributes to blood–brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder (2017) (32)
- Eculizumab improves fatigue in refractory generalized myasthenia gravis (2019) (32)
- Leukocytoclastic‐vasculitic neuropathy associated with chronic Epstein–Barr virus infection (2003) (30)
- Multiple angiogenetic factors are upregulated in POEMS syndrome (2012) (29)
- Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica (2010) (29)
- Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica (2016) (28)
- Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies (2015) (28)
- Identification of Cerebral Infarction-Specific Antibody Markers from Autoantibodies Detected in Patients with Systemic Lupus Erythematosus (2015) (27)
- Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica. (2017) (27)
- Elevated Levels of Autoantibodies against ATP2B4 and BMP-1 in Sera of Patients with Atherosclerosis-related Diseases (2015) (27)
- Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: Proteomic analysis (2010) (25)
- Epstein-Barr virus persistence and reactivation in neuromyelitis optica (2014) (25)
- Association of Serum Antibody Levels against TUBB2C with Diabetes and Cerebral Infarction (2015) (25)
- Acute isolated bulbar palsy with anti-GT1a IgG antibody subsequent to Campylobacter jejuni enteritis (2002) (25)
- Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: Evidence of activity-dependent conduction block (2013) (24)
- Current symptomatology in multiple sclerosis and neuromyelitis optica (2015) (24)
- Orthostatic hypotension in a case with multiple sclerosis (1997) (24)
- Anti-GQ1b antibody does not affect neuromuscular transmission in human limb muscle (2007) (24)
- Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan (2017) (23)
- Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy (2013) (22)
- Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus infection (2006) (22)
- First adult case of Helicobacter cinaedi meningitis (2014) (21)
- Mechanisms of early and late recovery in acute motor axonal neuropathy (2001) (21)
- Time course of axonal regeneration in acute motor axonal neuropathy (2007) (21)
- Anti-N-methyl d-aspartate-type glutamate receptor antibody-positive limbic encephalitis in a patient with multiple sclerosis (2012) (21)
- Increased ability of peripheral blood lymphocytes to degrade laminin in multiple sclerosis (2004) (21)
- Anti-aquaporin-4 antibody-seronegative NMO spectrum disorder with Baló's concentric lesions. (2013) (20)
- Serum SH3BP5-specific Antibody Level is a Biomarker of Atherosclerosis (2017) (20)
- Unilateral cranial and phrenic nerve involvement in axonal Guillain–Barré syndrome (2002) (18)
- Persistent hiccups followed by cardiorespiratory arrest (2012) (18)
- Superficial radial sensory nerve potentials in immune-mediated and diabetic neuropathies (2005) (18)
- Risk factors for fingolimod-induced lymphopenia in multiple sclerosis (2018) (16)
- Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial (2020) (16)
- Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis (2018) (16)
- Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis (2016) (15)
- Modulation of the kallikrein/kinin system by the angiotensin‐converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis (2014) (15)
- The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement (2019) (15)
- Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies (2019) (15)
- An Anti-Deoxyhypusine Synthase Antibody as a Marker of Atherosclerosis-Related Cerebral Infarction, Myocardial Infarction, Diabetes Mellitus, and Chronic Kidney Disease (2017) (15)
- Distribution of microsomal triglyceride transfer protein within sub-endoplasmic reticulum regions in human hepatoma cells. (2002) (15)
- Anti-MOG antibody–associated disorders: differences in clinical profiles and prognosis in Japan and Germany (2020) (15)
- In-vivo gene transfer into newly hatched chick brain by electroporation (2007) (14)
- Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world (2019) (14)
- Leucocytoclastic vasculitic neuropathy diagnosed by biopsy of normal appearing skin (2006) (14)
- Bickerstaff's brainstem encephalitis after an outbreak of Campylobacter jejuni enteritis (2008) (14)
- Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration (2018) (14)
- Peripheral blood helper T cell profiles and their clinical relevance in MOG-IgG-associated and AQP4-IgG-associated disorders and MS (2019) (14)
- When is neuromyelitis optica diagnosed after disease onset? (2012) (14)
- Neuromuscular transmission is not impaired in axonal Guillain–Barré syndrome (2010) (13)
- Urinary retention can be the sole initial manifestation of acute myelitis (2006) (13)
- Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines (2018) (13)
- Micturitional disturbance in a patient with adrenomyeloneuropathy (AMN) (1998) (12)
- Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study (2019) (12)
- Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis (2015) (12)
- Isolated abducens and facial nerve palsies due to a facial collicular plaque in multiple sclerosis (2010) (12)
- Intestinal pseudo‐obstruction and neuroleptic malignant syndrome in a chronically constipated parkinsonian patient (2006) (12)
- Long‐term regular plasmapheresis as a maintenance treatment for chronic inflammatory demyelinating polyneuropathy (2010) (11)
- Seasonality of multiple sclerosis and neuromyelitis optica exacerbations in Japan (2013) (11)
- Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases (2020) (11)
- Medulla and gut. (2004) (10)
- Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis. (2016) (10)
- Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (2021) (10)
- Detection of mumps virus RNA in cerebrospinal fluid of patients with neuromyelitis optica (2011) (10)
- Development of Isaacs' syndrome following complete recovery of voltage-gated potassium channel antibody-associated limbic encephalitis (2008) (10)
- Bilateral lesion in the lateral columns and complete urinary retention: Association with the spinal cord descending pathway for micturition (2005) (10)
- Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria (2016) (9)
- Identification of Serum Anti-GADD34 Antibody as a Common Marker ofDiabetes Mellitus and Parkinson Disease (2017) (9)
- Validation of the Modified Fatigue Impact Scale and the relationships among fatigue, pain and serum interleukin-6 levels in patients with neuromyelitis optica spectrum disorder (2018) (9)
- Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy (2015) (9)
- Soluble CD40 ligand disrupts the blood–brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis (2018) (9)
- Association of cognitive impairment with magnetic resonance imaging findings and social activities in patients with multiple sclerosis (2014) (9)
- Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis (2020) (9)
- Preparation of radioactive aldehyde-containing phosphatidylcholine. (2000) (9)
- Unilateral caudate head lesion simulating brain tumour in X-linked adult onset adrenoleukodystrophy (2001) (9)
- Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder (2017) (8)
- Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies (2017) (8)
- Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis (2021) (8)
- Fisher Syndrome (2011) (8)
- Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis (2016) (8)
- Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi‐center, open‐label, 52‐week phase 3 trial (2018) (7)
- Role of interleukin‐6 in the pathogenesis of neuromyelitis optica (2013) (7)
- Subacute combined degeneration of the spinal cord in vegetarians: vegetarian's myelopathy. (2006) (7)
- Characterization of vitronectins in atherosclerotic lesions. (1996) (7)
- Potassium channel antibody-associated encephalitis with hypothalamic lesions and intestinal pseudo-obstruction (2008) (7)
- Chronic inflammatory demyelinating polyneuropathy sera inhibit axonal growth of mouse dorsal root ganglion neurons by activation of rho‐kinase (2009) (7)
- [Molecular pathology in atherosclerosis: the mechanism by which cholesteryl ester accumulates in atheromatous aorta]. (2008) (6)
- Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD) (2016) (6)
- Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity (2017) (6)
- A patient with neuromyelitis optica with positive anti-Ro (SS-A) antibody presenting with intractable hiccup and nausea (2011) (6)
- Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke (2021) (6)
- Urinary symptoms and neurological disabilities are differentially correlated between multiple sclerosis and neuromyelitis optica (2016) (6)
- Pharmacokinetics of consecutive oral moxifloxacin (400 mg/day) in patients with respiratory tract infection (2016) (6)
- Guillain-Barré syndrome following hand-foot-and-mouth disease. (2000) (6)
- High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis (2021) (6)
- Relapse numbers and earlier intervention by disease modifying drugs are related with progression of less brain atrophy in patients with multiple sclerosis (2019) (6)
- Presence of Phospholipid-Neutral Lipid Complex Structures in Atherosclerotic Lesions as Detected by a Novel Monoclonal Antibody* (1999) (6)
- Serum Sphingosine 1-Phosphate (S1P): A Novel Diagnostic Biomarker in Early Acute Ischemic Stroke (2020) (5)
- Benign neuromyelitis optica is rare in Japanese patients (2015) (5)
- Retinol palmitate prevents ischemia-induced cell changes in hippocampal neurons through the Notch1 signaling pathway in mice (2013) (5)
- Atypical chronic inflammatory demyelinating polyneuropathies (2018) (5)
- AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders (2021) (5)
- Bickerstaff brainstem encephalitis after heat stroke (2006) (5)
- Are more sphingosine 1-phosphate receptor agonists a better therapeutic option against multiple sclerosis? (2014) (5)
- Is ‘Bickerstaff brainstem encephalitis’ really encephalitis? (2013) (5)
- Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited (2014) (5)
- A case of aneurysm of the carotid artery with main complaint of a neck mass (1995) (5)
- Seroconversion of anti-aquaporin-4 antibody in NMO spectrum disorder: a case report (2012) (5)
- Validation of the Japanese version of the Modified Fatigue Impact Scale and assessment of the effect of pain on scale responses in patients with multiple sclerosis (2015) (5)
- Lethal arrhythmia due to fingolimod, a S1P receptor modulator: are we overestimating or underestimating? (2015) (4)
- Ultrasound screening of urinary malformations in 'normal' newborns. (1996) (4)
- Bickerstaff brainstem encephalitis: more common than we think? (2013) (4)
- Diffuse neurosarcoidosis involving only the leptomeninges of the brainstem and spinal cord. (2009) (4)
- The 66, 56, 50, and 47 kDa Vitronectins in Atherosclerotic Lesions and in Serum (1994) (4)
- Serum levels of tumor necrosis factor-α in chronic inflammatory polyneuropathy (2001) (4)
- Steroid-Responsive Epilepsia Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy? (2014) (4)
- Accumulation of vitronectin in atherosclerotic lesions where lipids deposited. (1994) (4)
- Cognitive Impairment in Multiple System Atrophy Is Related to White Matter Damage Detected by the T1-Weighted/T2-Weighted Ratio (2021) (4)
- Chronic inflammatory demyelinating polyneuropathy: The spectrum and immunopathogenesis deciphered by electrophysiology and neuroimaging (2018) (3)
- Comparison of brain atrophy in patients with multiple sclerosis treated with first‐ versus second‐generation disease modifying therapy without clinical relapse (2020) (3)
- Adipose differentiation-related protein is degraded through the proteasome-dependent pathway during regression of lipid-storing cells (2005) (3)
- MOG antibody disorders and AQP4 antibody NMO spectrum disorders share a common immunopathogenesis (2018) (3)
- Bilateral Foot Acrocyanosis in an Interferon-β-treated MS Patient. (2016) (3)
- Peroxiredoxins are involved in the pathogenesis of multiple sclerosis and neuromyelitis optica spectrum disorder (2020) (3)
- Complete Relief of Painful Tonic Seizures in Neuromyelitis Optica Spectrum Disorder by Satralizumab Treatment (2022) (3)
- [Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus]. (2015) (3)
- Clumsy hand syndrome due to a localised cortical lesion in the primary sensory cortex in neuromyelitis optica (2011) (3)
- Paranodal destruction and axo-glial dysjunction in a subtype of CIDP with anticontaction-1 antibodies (2015) (3)
- Fatal Invasive Cryptococcal Infection in an HIV-Negative Elderly Patient with Decompensated Hepatic Cirrhosis (2018) (3)
- Different patterns of brainstem and cerebellar MRI abnormalities in demyelinating disorders with MOG and aquaporin-4 antibodies (2021) (2)
- Quotient of cerebrospinal fluid/serum immunoglobulin G as a predictive factor for non‐responders to intravenous methylprednisolone therapy in patients with relapsing neuromyelitis optica spectrum disorder: Implication for early initiation of plasmapheresis (2016) (2)
- Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders (2018) (2)
- Anatomical connectivity elucidated by analysing thalamic atrophy in neuromyelitis optica (2019) (2)
- Neuroimmunology of a natural disaster (2016) (2)
- Chronic Hypertensive Encephalopathy Showing Only Headache: Report of a Case with Long-Standing Brain MR Abnormalities Suggesting Extensive Vasogenic Edema (2005) (2)
- WITHDRAWN: Cognitive impairment in multiple system atrophy is related to white matter damage detected by the T1w/T2w ratio (2020) (2)
- Autoimmune polyendocrine syndrome type 3 in a multiple sclerosis patient (2015) (2)
- A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain (2014) (2)
- [Paraneoplastic limbic encephalitis]. (2004) (2)
- Author response. (2014) (2)
- Dementia and Parkinson-like syndrome with basal ganglia lesion in neuromyelitis optica spectrum disorders (2021) (2)
- Serum cytokine and chemokine profiles in patients with juvenile muscular atrophy of distal upper extremity (Hirayama disease) (2017) (2)
- Cultural bias in motor function patterns: Potential relevance for predictive, preventive, and personalized medicine (2021) (2)
- Efficacy and safety of dimethyl fumarate in treatment-naïve Japanese patients with multiple sclerosis: Interim analysis of the randomized placebo-controlled study (2019) (2)
- Selective alpha 1A-blocker “silodosin” safety improves female lower urinary tract dysfunctions (2011) (1)
- Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma (2022) (1)
- [Meatal advancement and glanuloplasty incorporated (MAGPI): a new surgical technic in the treatment of distal hypospadias]. (1985) (1)
- Change in vital signs after fingolimod initiation in patients with multiple sclerosis: the possible need for 24 h monitoring. (2015) (1)
- Efficient total analyses for bromine type flame retardants by simple NICI-GC/MS (2013) (1)
- Subcortical Hearing Disorders: Report of 2 Cases (1992) (1)
- Upbeat nystagmus at caudal brainstem lesions in four cases with multiple sclerosis and its related disorders (2013) (1)
- Short communication Hyperreflexia in axonal Guillain-Barresyndrome subsequent to Campylobacter jejuni enteritis (2002) (1)
- Isolated ocular flutter (2013) (1)
- Analysis of Anti-JCV antibody in Japanese patients with multiple sclerosis (2017) (1)
- Retinal Sensitivity Reduced in Patients with Neuromyelitis Optica Spectrum Disorder with no History of Optic Neuritis (2015) (1)
- Cognition with magnetic resonance imaging findings and social activities in patients with multiple sclerosis in a Japanese cohort (2018) (1)
- Relapse of Neuromyelitis Optica Spectrum Disorder Associated with Intravenous Lidocaine (2011) (1)
- [Guillain-Barré syndrome following cytomegalovirus infection with increased level of antibody against moesin-a case report]. (2018) (1)
- A case report of neuromyelitis optica spectrum disorder induced by pembrolizumab treatment for lung adenocarcinoma: a clinical and immunohistochemical study (2022) (1)
- Clinical difference after the first optic neuritis between aquaporin-4-IgG-associated and myelin oligodendrocyte glycoprotein-IgG-associated disorders (2021) (1)
- Environment surrounding the ganglioside clusters as immunological targets in Guillain–Barré syndrome (2013) (0)
- Prevalence and mechanism of urinary dysfunction in Guillain-Barre syndrome (2008) (0)
- Useful scales for recognition of severe disease status in patients with multiple sclerosis in Japan (2017) (0)
- MULTIPLE TRICHOEPITHELIOMAS AND MALIGNANT ACROSPIROMAS (1994) (0)
- Health-related quality of life in Japanese patients with multiple sclerosis (2022) (0)
- Elevated serum levels of bone morphogenetic protein-9 are associated with better outcome in AQP4-IgG seropositive NMOSD (2023) (0)
- Hyperbaric Oxigen-Induced Secretory Otitis Media. (1991) (0)
- Questionnaire-based assessments of the differences in the urinary symptoms in multiple sclerosis and neuromyelitis optica (2013) (0)
- Cell-based flow cytometry assay for simultaneous detection of multiple autoantibodies in a single serum sample. (2022) (0)
- Cryptococcal Meningitis in a Fingolimod-Treated Patient: Positive Antigen Test a Year Before Onset. (2021) (0)
- Intravenous versus subcutaneous immunoglobulin – Authors' reply (2018) (0)
- Soluble Talin-1 and Anti-talin-1 antibody are associated with pathogenesis of multiple sclerosis and may be as biomarker for the disease (2017) (0)
- Remyelination and neuroprotective effects of alemtuzumab therapy in patients with multiple sclerosis (2021) (0)
- Efficacy and safety of delayed-release dimethyl fumarate in treatment-naïve Japanese patients with relapsing-remitting multiple sclerosis: A post-hoc subgroup analysis of the apex study (2017) (0)
- [Blood and cerebrospinal fluid test in multiple sclerosis]. (2015) (0)
- Pheochromocytoma with predominant epinephine secretion accompanied by variable arrhythmias (1985) (0)
- A case of anti-aquaporin-4 antibody-seronegative NMO spectrum disorder with Baló concentric lesions. (2014) (0)
- The role of granulocyte‐macrophage colony‐stimulating factor in the pathogenesis of neuromyelitis optica: A white or black knight? (2015) (0)
- Insights from the differences in clinical profiles of neuroimmune disorders between patients in Japan and those in Western countries (2021) (0)
- Scaling Levels of Dysphagia (1993) (0)
- Methodology for identification of new target molecules in neuroimmunological disorders (2021) (0)
- Guillain–Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines: The risks and benefits (2013) (0)
- Multiple enhancing brain lesions after discontinuation of fingolimod in a patient with multiple sclerosis (2014) (0)
- [Vesico-renal reflux caused by neurogenic bladder from spina bifida in childhood]. (1986) (0)
- [Target Molecule for a Demyelinating Type of Guillain-Barré Syndrome, Acute Inflammatory Demyelinating Polyneuropathy]. (2015) (0)
- Search for serum autoantibodies in Amyotrophic lateral sclerosis (2017) (0)
- Th-P15:39 Foam cell death induced by hyperlipidemic serum is related to phosphatidylcholine cholesterol complex formation (2006) (0)
- CSF IL-6 study in neurological disorders with a special focus on Neuromyelitis optica (2017) (0)
- Asialo GM2 which has developed on atheromatous fatty streaks can be detected by a novel monoclonal antibody (ASH1a/256C) (1994) (0)
- [Alemtuzumab, a monoclonal antibody against CD52: hopes and fears]. (2014) (0)
- Mechanism of Lipid Accumulation in Arterial Walls: -Analysis by Monoclonal Antibodies Recognizing Atherosclerotic Lesions- (1994) (0)
- [Indications for diagnostic and surgical digestive endoscopy in childhood: personal clinical experience]. (1985) (0)
- Hypo- and hyper-active lumbosacral nerves cause urinary dysfunction in Guillain–Barré syndrome (2007) (0)
- 4P-0959 PC-choleserol complex correlates from cell rupture (2003) (0)
- [Novel therapeutic target in neuromyelitis optica and multiple sclerosis: high mobility group box 1 (HMGB1)]. (2014) (0)
- Severe orthostatic hypotension associated with lesions of the area postraema in neuromyelitis optica spectrum disorder (2021) (0)
- Soluble CD40 ligand contributes to blood–brain barrier breakdown and central nervous system inflammation (2017) (0)
- Abstract: P725 PC-CHOLESTEROL COMPLEX AS A NOVEL MARKER FOR FOAM CELL DEATH CAN BE SUPPRESSED BY VASCULAR STATIN (2009) (0)
- Lysosomal accumulation of oxidized PC-apoB complex derived from oxidized LDL in macrophages (2000) (0)
- A CASE OF PRIMARY DUODENAL CANCER OF ULCERATING TYPE IN THE INFRAPAPILLARY REGION (1989) (0)
- Asialo GM‐2 Developed on the Fatty Streak of Atherosclerotic Aorta Detected by a Novel Monoclonal Antibody (ASH1a/256C) (1994) (0)
- Serum cytokine profiles of chronic inflammatory demyelinating polyneuropathy (2013) (0)
- Subject Index Vol. 51, 2004 (2004) (0)
- Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder (2017) (0)
- Soluble CD40 ligand contributes to blood-brain barrier breakdown in patients with multiple sclerosis and mice with experimental autoimmune encephalomyelitis (2018) (0)
- [Gastro-esophageal reflux in childhood. When to operate?]. (1985) (0)
- and Satoshi multiple sclerosis ' ' Bright spotty lesions ' ' on spinal magnetic resonance imaging differentiate neuromyelitis optica (2013) (0)
- Contents Vol. 51, 2004 (2004) (0)
- Cultural bias in motor function patterns: Potential relevance for predictive, preventive, and personalized medicine (2021) (0)
- Micturitional disturbance in a patient with a spinal cavernous angioma (2003) (0)
- Severe Subcutaneous Calcification in an Interferon-β-treated MS Patient (2017) (0)
- [Role of serum pepsinogen I values in primary duodenal ulcer in childhood]. (1986) (0)
- Partialis Continua with Anti-Thyroid Antibodies: A Spectrum of Hashimoto's Encephalopathy? (2014) (0)
- Correlation of the symbol digit modalities test with the quality of life and depression in Japanese patients with multiple sclerosis. (2021) (0)
- Short communication Potassium channel antibody-associated encephalitis with hypothalamic lesions and intestinal pseudo-obstruction (2008) (0)
- Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis (2019) (0)
- [Paraneoplastic subacute motor neuropathy]. (2000) (0)
- Moesin, membrane‐organizing extension spike protein, is a possible immunological target in Guillain–Barré syndrome after cytomegalovirus infection (2015) (0)
- Identification of novel candidate autoantigens in multiple sclerosis by expression cloning (2013) (0)
- Schwannoma of Cervical Vagus Nerve; a Report of Three Cases (1995) (0)
- Clinical features, treatments, and prognoses of patients with multiple sclerosis in Chiba Prefecture (2006) (0)
- The difference of intercellular cytokine profiles among MOG+CNS disorders, AQP4+NMOSD, and MS patients (2018) (0)
- Immunological differences between neuromyelitis optica and multiple sclerosis (2011) (0)
- [Primary vesico-ureteral reflux: current therapeutic trends]. (1987) (0)
- Correspondence to childhood intractable feeding and swallowing problems (2012) (0)
- Causal Factors of Repeated Fractures in a Female Patient with Parkinson's Disease (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Masahiro Mori?
Masahiro Mori is affiliated with the following schools:
